Loading

Financial Press Releases

About Avicanna

Strategically positioned to be a front runner in the;
• Development
• Manufacturing and;
• Commercialization of plant-derived cannabinoid-based products

Nov 14, 2019

Avicanna Reports Third Quarter 2019 Financial Results

TORONTO, Nov. 14, 2019 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces results …

Aug 23, 2019

Avicanna Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes

TORONTO, Aug. 23, 2019 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) a biopharmaceutical company …

Aug 14, 2019

Avicanna Reports Second Quarter 2019 Financial Results

TORONTO, Aug. 14, 2019 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces results for the second quarter …

July 18, 2019

Avicanna Commences Trading on the TSX Under the Symbol "AVCN"

TORONTO, July 18, 2019 /CNW/ – Avicanna Inc. (“Avicanna”) a company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that its common shares …

avica_white

480 University Ave, Suite 1502
Toronto, ON M5G 1V2
Canada

Want to stay up to date? Subscribe to receive email updates.

           
© 2017-2019 Avicanna Inc. All Rights Reserved.
Subscribe
SUBSCRIBE NOW

Sign up and join our Newsletter  

Stay updated with all latest
updates and news.
close-link